不孕症治療服務市場規模、佔有率和成長分析（按類型、程序、服務、最終用戶和地區）- 產業預測 2025-2032

不孕症治療服務市場規模預計到 2023 年將達到 438.4 億美元，並從 2024 年的 477.4 億美元成長到 2032 年的 944.3 億美元，預測期內（2025-2032 年）的複合年成長率為 8.9%。

由於結婚延遲、避孕選擇增加以及注重職業發展等因素，社會轉向延遲生育，大大增加了對生育治療服務的需求。根據聯合國的報告，在法國等國家，初為人母的平均年齡在20多歲至30出頭之間。這種變化與不孕率的上升有關，導致許多女性尋求輔助生殖技術（ART）作為解決生育問題的有效方法。由於延遲懷孕會降低自然受孕的機會，越來越多的夫婦開始採用輔助生殖技術來實現計劃生育。這些情況的變化明確地表明，不孕症治療的需求正在增加，市場狀況有望大幅擴大。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管格局

不孕症治療服務市場規模（按類型和複合年成長率）（2025-2032）

• 市場概況
• 診斷
• 治療
• 保持

不孕症治療服務市場規模（按程序和複合年成長率） (2025-2032)

• 市場概況
• 體外受精 (IVF) 與卵卵細胞質內單一精蟲顯微注射術(ICSI)
• 子宮內授精 (IUI)
• 體外受精（IVF）而不使用ICSI
• 代孕
• 其他程式

不孕症治療服務市場規模（依服務類型及複合年成長率） (2025-2032)

• 市場概況
• 新的非捐贈者
• 冷凍非捐贈者
• 卵子/胚胎儲存
• 新捐款者
• 凍結捐贈者

不孕症治療服務市場規模（依最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 不孕不育診所
• 醫院
• 手術中心
• 臨床研究所

不孕症治療服務市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Merck KGaA（Germany）
• Vitrolife AB（Sweden）
• Monash IVF Group（Australia）
• Genea Limited（Australia）
• Progyny, Inc.（United States）
• Ferring Pharmaceuticals（Switzerland）
• CooperSurgical, Inc.（United States）
• Cook Medical Inc.（United States）
• The Cooper Companies, Inc.（United States）
• Virtus Health（Australia）
• Cryos International（Denmark）
• Carolinas Fertility Institute（United States）
• Apollo Fertility（India）
• Bloom IVF Centre（India）
• Bangkok IVF Center（Thailand）
• Medicover Fertility（Sweden）

結論和建議

Fertility Services Market size was valued at USD 43.84 billion in 2023 and is poised to grow from USD 47.74 billion in 2024 to USD 94.43 billion by 2032, growing at a CAGR of 8.9% during the forecast period (2025-2032).

The societal shift towards delayed motherhood, driven by factors such as delayed marriages, enhanced birth control options, and a focus on career advancement, has notably increased the demand for fertility services. The United Nations reports a trend in countries like France where the average age of first-time mothers is now in their late twenties to early thirties. This shift correlates with rising infertility rates, prompting many women to seek Assisted Reproductive Technology (ART) as a viable solution to conception challenges. As the biological window for natural conception narrows due to postponed pregnancies, couples are increasingly turning to ART to facilitate family planning. This evolving landscape underscores the growing necessity for fertility treatments, positioning the fertility services market for significant expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Fertility Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Fertility Services Market Segments Analysis

Global Fertility Services Market is segmented by Type, Procedure, Service, End-User and region. Based on Type, the market is segmented into Diagnosis, Treatment and Preservation. Based on Procedure, the market is segmented into In Vitro Fertilization (IVF) with Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), IVF without ICSI, Surrogacy and Other Procedures. Based on Service, the market is segmented into Fresh Non-donor, Frozen Non-donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor. Based on End-User, the market is segmented into Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Fertility Services Market

The growth of the fertility services market is primarily driven by rising infertility rates, which are often attributed to factors such as stress, the decision to delay parenthood, and various lifestyle changes. Furthermore, issues like obesity, smoking, and exposure to environmental pollutants exacerbate the challenges encountered by individuals experiencing reproductive health difficulties. As the demand for effective solutions increases, advancements in assisted reproductive technology (ART) have significantly enhanced treatment options, reflecting the ongoing response to these evolving challenges in fertility management. Overall, these interconnected factors are fueling the expansion of the fertility services sector.

Restraints in the Fertility Services Market

The fertility services market faces significant constraints due to a variety of moral and legal issues associated with reproductive interventions. Practices such as embryo freezing, surrogacy, and egg donation often encounter opposition rooted in religious and cultural beliefs, which can vary widely across different regions. Additionally, the presence of varying legislation in different countries complicates access to these treatments, limiting opportunities for individuals seeking assistance across borders. This legal framework and the associated cultural challenges hinder the widespread acceptance and implementation of assisted reproductive technologies, ultimately impacting the growth and accessibility of fertility services in the market.

Market Trends of the Fertility Services Market

The Fertility Services market is witnessing a notable trend towards the growing adoption of fertility preservation techniques, driven primarily by shifting societal norms and lifestyle choices. As delayed parenthood rises, particularly among millennials, there is a marked increase in demand for services such as egg and sperm freezing. This trend is further fueled by medical conditions necessitating preservation for health reasons. Consequently, innovations in cryopreservation technologies are gaining traction, contributing to the expansion of fertility services globally. This evolving landscape not only reflects changing attitudes towards family planning but also highlights the urgent need for accessible and advanced fertility solutions in today's market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Fertility Services Market Size by Type & CAGR (2025-2032)

• Market Overview
• Diagnosis
• Treatment
• Preservation

Global Fertility Services Market Size by Procedure & CAGR (2025-2032)

• Market Overview
• In Vitro Fertilization (IVF) with Intracytoplasmic Sperm Injection (ICSI)
• Intrauterine Insemination (IUI)
• IVF without ICSI
• Surrogacy
• Other Procedures

Global Fertility Services Market Size by Service & CAGR (2025-2032)

• Market Overview
• Fresh Non-donor
• Frozen Non-donor
• Egg & Embryo Banking
• Fresh Donor
• Frozen Donor

Global Fertility Services Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Fertility Clinics
• Hospitals
• Surgical Centers
• Clinical Research Institutes

Global Fertility Services Market Size & CAGR (2025-2032)

• North America (Type, Procedure, Service, End-User)
  • US
  • Canada
• Europe (Type, Procedure, Service, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Procedure, Service, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Procedure, Service, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Procedure, Service, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitrolife AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Monash IVF Group (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genea Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Progyny, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring Pharmaceuticals (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Cooper Companies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virtus Health (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cryos International (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carolinas Fertility Institute (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apollo Fertility (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bloom IVF Centre (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bangkok IVF Center (Thailand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medicover Fertility (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations